STAT3 shRNA

STAT3 shRNA is a laboratory-designed short hairpin RNA molecule engineered to specifically target and silence the expression of the STAT3 (Signal Transducer and Activator of Transcription 3) gene. STAT3 acts as a transcriptional regulator involved in cell proliferation, survival, and immune function, and is frequently overactivated in cancer. STAT3 shRNA is delivered using vectors such as lentiviruses or plasmids, leading host cells to produce shRNA that triggers RNA interference (RNAi), resulting in the degradation of STAT3 mRNA and suppression of STAT3 protein synthesis. In preclinical cancer models including various carcinoma cell lines, STAT3 shRNA knockdown reduces STAT3 mRNA and protein levels, decreasing cell proliferation, inducing apoptosis, and enhancing sensitivity to other therapies such as radiation. Therapeutically, STAT3 shRNA is an experimental genetic tool, not a commercial drug, and is being explored in gene therapy research for targeted cancer treatment[1][2][4][5][7].

Other names

STAT3 short hairpin RNASTAT-3 short hairpin RNASTAT 3 short hairpin RNASTAT3-targeted shRNASTAT-3-targeted shRNASTAT 3-targeted shRNA